• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥运会治疗用药豁免的流行情况及其与奖牌的关系:2010 年至 2018 年数据分析。

Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.

机构信息

Science and Medicine, World Anti-Doping Agency, Montreal, Quebec, Canada

Science and Medicine, World Anti-Doping Agency, Montreal, Quebec, Canada.

出版信息

Br J Sports Med. 2020 Aug;54(15):920-924. doi: 10.1136/bjsports-2020-102028. Epub 2020 May 6.

DOI:10.1136/bjsports-2020-102028
PMID:32376674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7392493/
Abstract

OBJECTIVES

The percentage of athletes with Therapeutic Use Exemptions (TUEs) competing in elite sport and the association with winning medals has been a matter of speculation in the absence of validated competitor numbers. We used International Olympic Committee (IOC) and World Anti-Doping Agency (WADA) data to identify athletes competing with TUEs at five Olympic Games (Games) and a possible association between having a TUE and winning an Olympic medal.

METHODS

We used the IOC's competition results and WADA's TUE database to identify the number of TUEs for athlete competitions (ACs, defined as one athlete competing in one event) and any associations with medals among athletes competing in individual competitions. We calculated risk ratios (RR) for the probability of winning a medal among athletes with a TUE compared with that of athletes without a TUE. We also reported adjusted RR (RR) controlling for country resources, which is a potential confounder.

RESULTS

During the Games from 2010 to 2018, there were 20 139 ACs and 2062 medals awarded. Athletes competed with a TUE in 0.9% (181/20 139) of ACs. There were 21/2062 medals won by athletes with a TUE. The RR for winning a medal with a TUE was 1.13 (95% CI: 0.73 to 1.65; p=0.54), and the RR was 1.07 (95% CI: 0.69 to 1.56; p=0.73).

CONCLUSION

The number of athletes competing with valid TUEs at Games is <1%. Our results suggested that there is no meaningful association between being granted a TUE and the likelihood of winning a medal.

摘要

目的

在缺乏经过验证的参赛选手数量的情况下,有治疗用药豁免(TUE)的运动员在精英体育赛事中的参赛比例及其与获得奖牌之间的关联一直是人们猜测的话题。我们使用国际奥林匹克委员会(IOC)和世界反兴奋剂机构(WADA)的数据,在五届奥运会(奥运会)中确定了使用 TUE 参赛的运动员人数,以及 TUE 与获得奥运会奖牌之间的可能关联。

方法

我们使用国际奥委会的比赛结果和世界反兴奋剂机构的 TUE 数据库,确定了运动员比赛中 TUE 的数量(AC,定义为一名运动员参加一项比赛),以及在个人比赛中参赛运动员获得奖牌的任何关联。我们计算了 TUE 运动员与无 TUE 运动员获得奖牌的概率之间的风险比(RR)。我们还报告了在控制国家资源(这是一个潜在的混杂因素)后调整的 RR(RR)。

结果

在 2010 年至 2018 年奥运会期间,有 20139 个 AC 和 2062 枚奖牌。有 181 名运动员在 0.9%(181/20139)的 AC 中使用 TUE 参赛。有 21 枚奖牌被使用 TUE 的运动员获得。TUE 运动员获得奖牌的 RR 为 1.13(95% CI:0.73 至 1.65;p=0.54),RR 为 1.07(95% CI:0.69 至 1.56;p=0.73)。

结论

在奥运会上使用有效 TUE 参赛的运动员人数<1%。我们的结果表明,获得 TUE 与获得奖牌的可能性之间没有明显的关联。

相似文献

1
Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.奥运会治疗用药豁免的流行情况及其与奖牌的关系:2010 年至 2018 年数据分析。
Br J Sports Med. 2020 Aug;54(15):920-924. doi: 10.1136/bjsports-2020-102028. Epub 2020 May 6.
2
Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.1992-2012 年奥运会治疗用药豁免(TUE)。
Br J Sports Med. 2013 Sep;47(13):815-8. doi: 10.1136/bjsports-2013-092460. Epub 2013 Apr 16.
3
Prevalence of therapeutic use exemptions at the Olympic Games and Paralympic Games: an analysis of data from 2016 to 2022.奥运会和残奥会治疗用药豁免的流行情况:2016 年至 2022 年数据的分析。
Br J Sports Med. 2024 Sep 4;58(17):966-972. doi: 10.1136/bjsports-2024-108266.
4
Therapeutic Use Exemptions.治疗用药豁免
Med Sport Sci. 2017;62:55-67. doi: 10.1159/000460700. Epub 2017 Jun 1.
5
Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.平昌 2018 年冬奥会和冬残奥会的药学服务。
Br J Sports Med. 2019 Sep;53(17):1105-1110. doi: 10.1136/bjsports-2018-100069. Epub 2019 Mar 20.
6
Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.在治疗和提高表现之间:一项关于精英运动员如何体验治疗用药豁免的调查。
Int J Drug Policy. 2013 Nov;24(6):579-88. doi: 10.1016/j.drugpo.2013.03.007. Epub 2013 Apr 9.
7
Doping control from a global and national perspective.从全球和国家视角看兴奋剂检查
Ther Drug Monit. 2004 Apr;26(2):171-4. doi: 10.1097/00007691-200404000-00015.
8
Therapeutic Use Exemptions (TUEs) are essential in sport: but there is room for improvement.治疗用药豁免(TUEs)在体育界至关重要:但仍有改进空间。
Br J Sports Med. 2020 Feb;54(3):191-192. doi: 10.1136/bjsports-2018-100113. Epub 2019 Apr 18.
9
Proscribed drugs at the Olympic Games: permitted use and misuse (doping) by athletes.奥运会禁用药物:运动员的允许使用和误用(兴奋剂)。
Clin Med (Lond). 2012 Jun;12(3):257-60. doi: 10.7861/clinmedicine.12-3-257.
10
Career factors related to winning Olympic medals in swimming.与游泳奥运奖牌相关的职业因素。
PLoS One. 2024 Jun 28;19(6):e0304444. doi: 10.1371/journal.pone.0304444. eCollection 2024.

引用本文的文献

1
Prevalence of therapeutic use exemptions at the Olympic Games and Paralympic Games: an analysis of data from 2016 to 2022.奥运会和残奥会治疗用药豁免的流行情况:2016 年至 2022 年数据的分析。
Br J Sports Med. 2024 Sep 4;58(17):966-972. doi: 10.1136/bjsports-2024-108266.
2
Acute Effects of Single Versus Combined Inhaled β2-Agonists Salbutamol and Formoterol on Time Trial Performance, Lung Function, Metabolic and Endocrine Variables.单次吸入与联合吸入β2受体激动剂沙丁胺醇和福莫特罗对计时赛成绩、肺功能、代谢及内分泌变量的急性影响。
Sports Med Open. 2023 Aug 28;9(1):79. doi: 10.1186/s40798-023-00630-3.
3
Sex Differences in Athletic Performance: Perspectives on Transgender Athletes.性别在运动表现中的差异:跨性别运动员的观点。
Exerc Sport Sci Rev. 2023 Jul 1;51(3):85-95. doi: 10.1249/JES.0000000000000317. Epub 2023 Apr 14.
4
Prevalence of Prohibited Substance Use and Methods by Female Athletes: Evidence of Gender-Related Differences.女运动员违禁药物使用情况及方式:性别相关差异的证据
Front Sports Act Living. 2022 May 24;4:839976. doi: 10.3389/fspor.2022.839976. eCollection 2022.

本文引用的文献

1
Glucocorticoids in elite sport: current status, controversies and innovative management strategies-a narrative review.精英运动中的糖皮质激素:现状、争议和创新管理策略——叙述性综述。
Br J Sports Med. 2020 Jan;54(1):8-12. doi: 10.1136/bjsports-2018-100196. Epub 2019 Jul 20.
2
Doping in Sports, a Never-Ending Story?体育界的兴奋剂问题,是个没完没了的故事?
Adv Pharm Bull. 2018 Nov;8(4):529-534. doi: 10.15171/apb.2018.062. Epub 2018 Nov 29.
3
Brief History of Anti-Doping.反兴奋剂简史
Med Sport Sci. 2017;62:1-10. doi: 10.1159/000460680. Epub 2017 Jun 1.
4
Airway dysfunction in elite swimmers: prevalence, impact, and challenges.精英游泳运动员的气道功能障碍:患病率、影响及挑战。
Open Access J Sports Med. 2016 May 12;7:55-63. doi: 10.2147/OAJSM.S88339. eCollection 2016.
5
Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.1992-2012 年奥运会治疗用药豁免(TUE)。
Br J Sports Med. 2013 Sep;47(13):815-8. doi: 10.1136/bjsports-2013-092460. Epub 2013 Apr 16.
6
Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.在治疗和提高表现之间:一项关于精英运动员如何体验治疗用药豁免的调查。
Int J Drug Policy. 2013 Nov;24(6):579-88. doi: 10.1016/j.drugpo.2013.03.007. Epub 2013 Apr 9.
7
Sports in extreme conditions: the impact of exercise in cold temperatures on asthma and bronchial hyper-responsiveness in athletes.极端条件下的运动:寒冷环境下运动对运动员哮喘和支气管高反应性的影响。
Br J Sports Med. 2012 Sep;46(11):796-9. doi: 10.1136/bjsports-2012-091292.
8
An overview of asthma and airway hyper-responsiveness in Olympic athletes.奥林匹克运动员的哮喘和气道高反应性概述。
Br J Sports Med. 2012 May;46(6):413-6. doi: 10.1136/bjsports-2011-090814. Epub 2012 Jan 8.
9
Genetics of complex airway disease.复杂气道疾病的遗传学。
Proc Am Thorac Soc. 2011 May;8(2):149-53. doi: 10.1513/pats.201101-003MS.
10
The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.哮喘运动员:吸入β2 激动剂、运动表现和兴奋剂。
Clin J Sport Med. 2011 Jan;21(1):46-50. doi: 10.1097/IAE.0b013e318203c0ef.